Ertugliflozin and sitagliptin
Generic name: Ertugliflozin And Sitagliptin
Brand names: Steglujan
Dosage form: oral tablet (15 mg-100 mg; 5 mg-100 mg)
Drug class:
Antidiabetic combinations
Usage of Ertugliflozin and sitagliptin
Ertugliflozin and sitagliptin is a combination medicine used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. ertugliflozin and sitagliptin is not for treating type 1 diabetes.
Ertugliflozin and sitagliptin may also be used for purposes not listed in this medication guide.
Ertugliflozin and sitagliptin side effects
Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling).
Seek medical attention right away if you have signs of a rare but serious genital infection (penis or vagina): burning, itching, odor, discharge, pain, tenderness, redness or swelling of the genital or rectal area, fever, not feeling well. These symptoms may get worse quickly.
Ertugliflozin and sitagliptin may cause serious side effects. Call your doctor at once if you have:
Some side effects may be more likely to occur in older adults.
Common side effects of ertugliflozin and sitagliptin may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Ertugliflozin and sitagliptin
You should not use this medicine if you are allergic to ertugliflozin o sitagliptin, or if you have:
Tell your doctor if you have ever had:
Follow your doctor's instructions about using this medicine if you are pregnant. Blood sugar control is very important during pregnancy, and your dose needs may be different during each trimester.
You should not use ertugliflozin and sitagliptin during the second or third trimester of pregnancy.
You should not breastfeed while using this medicine.
Ertugliflozin and sitagliptin is not approved for use by anyone younger than 18 years old.
Relate drugs
- Actoplus Met
- Actoplus Met XR
- Alogliptin and metformin
- Alogliptin and pioglitazone
- Avandamet
- Avandaryl
- Canagliflozin and metformin
- Dapagliflozin and metformin
- Dapagliflozin and saxagliptin
- Duetact
- Empagliflozin and linagliptin
- Empagliflozin and metformin
- Empagliflozin, linagliptin, and metformin
- Ertugliflozin and metformin
- Ertugliflozin and sitagliptin
- Glimepiride and pioglitazone
- Glipizide and metformin
- Glucovance
- Glyburide and metformin
- Glyxambi
- Insulin degludec and liraglutide
- Insulin glargine and lixisenatide
- Invokamet
- Invokamet XR
- Janumet
- Janumet XR
- Jentadueto
- Jentadueto XR
- Kazano
- Kombiglyze XR
- Linagliptin and metformin
- Metaglip
- Metformin and pioglitazone
- Metformin and saxagliptin
- Metformin and sitagliptin
- Oseni
- Pioglitazone and glimepiride
- Pioglitazone and metformin
- PrandiMet
- Qtern
- Repaglinide and metformin
- Rosiglitazone and glimepiride
- Rosiglitazone and metformin
- Saxagliptin and dapagliflozin
- Saxagliptin and metformin
- Segluromet
- Sitagliptin and metformin
- Soliqua
- Soliqua 100/33
- Steglujan
- Synjardy
- Synjardy XR
- Trijardy XR
- Xigduo XR
- Xultophy
How to use Ertugliflozin and sitagliptin
Usual Adult Dose for Diabetes Type 2:
Initial dose: 1 tablet (ertugliflozin 5 mg/sitagliptin 100 mg) orally once a day -For patients tolerating therapy and requiring additional glycemic control, may increase to 1 tablet (ertugliflozin 15 mg/sitagliptin 100 mg) orally once a dayMaximum dose: ertugliflozin 15 mg/sitagliptin 100 mg per dayFor patients already receiving ertugliflozin: Switch to combination product with same ertugliflozin doseComments:-Volume depletion should be corrected prior to initiating therapy. -This drug is not recommended for patients with type 1 diabetes mellitus as it may increase the risk of diabetic ketoacidosis in these patients. -This drug has not been studied in patients with a history of pancreatitis; it is not known whether this may increase the risk of developing pancreatitis during therapy. Use: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Warnings
Stop taking ertugliflozin and sitagliptin and call your doctor right away if you have symptoms of pancreatitis: severe pain in your upper stomach spreading to your back, with or without nausea and vomiting.
In rare cases, ertugliflozin and sitagliptin can cause serious infections in the penis or vagina. Get medical help right away if you have burning, itching, odor, discharge, pain, tenderness, redness or swelling of the genital or rectal area, fever, or if you don't feel well.
What other drugs will affect Ertugliflozin and sitagliptin
When you start or stop taking ertugliflozin and sitagliptin, your doctor may need to adjust the doses of any other diabetes medicines you use on a regular basis.
Other drugs may affect ertugliflozin and sitagliptin, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions